| Description | This product is a monoclonal antibody derived from Mouse (Mus musculus), which can specifically recognize CD22 molecule. The antibody is expressed with mammalian cell transient expression system, serum-free and purified by affinity chromatography. The purity and integrity are tested via SDS-PAGE and SEC-HPLC analysis. Given an antigen, additional QC measures are also desired such as affinity testing and binding validation. Specifically, the antibody is provided in multiple formats for in vivo and in vitro assays. The Invivo version features greater than 95% purity, ultra-low endotoxin levels (<1 EU/mg or 0.1 EU/mg), and is preservative, stabilizer, and carrier protein-free. |
| Clonality | Monoclonal |
| Host Species | Mouse |
| Target Species | Human |
| Isotype | IgG |
| Expression Species | HEK293F or CHO |
| Conjugation | None |
| Purity | >95%, determined by SDS-PAGE and/or SEC-HPLC |
| Endotoxin | <1 EU/mg, determined by LAL method |
| Purification | Protein A affinity purified |
| Sterility | 0.2 μM filtered |
| Formulation | PBS, pH 7.4 |
| Preservation | No preservatives |
| Stabilizer | No stabilizers |
| Storage | Store at 4⁰C within a week. For longer storage, aliquot and store at -20⁰C. |
| Application | WB; DB; FC; ELISA |
| Application Notes | The antibody is recommended for detection of CD22 by ELISA assay. |
| ELISA | Enzyme-Linked Immunosorbent Assay Protocol |
| WB | Western Blot Protocol |
| FC | Flow Cytometry Protocol |
| Target | CD22 |
| Alternative Name | CD22 Molecule; CD22 Antigen; Sialic Acid Binding Ig-Like Lectin 2; Sialic Acid-Binding Ig-Like Lectin 2; B-Lymphocyte Cell Adhesion Molecule; T-Cell Surface Antigen Leu-14; SIGLEC-2; SIGLEC2; BL-CAM |
| Gene ID | 933 |
| UniProt | P20273 |
| Research Area | Immunology; Cancer Research |
| Related Disease | B-cell associated diseases, such as B-cell malignancies, autoimmune disease and immune dysfunction disease |
Figure 1 Anti-CD22 Monoclonal Antibody (V3S-0522-YC6553) in ELISA
ELISA analysis of V3S-0522-YC6553 was performed by coating with Human CD22 Protein (His Tag). Then blocked with BSA and incubated with V3S-0522-YC6553. The HRP-conjugated goat anti-mouse IgG as a secondary antibody (1: 5000). Detection was performed using TMB substrate and stopped with sulfuric acid. The absorbances were read on a spectrophotometer at 450 nm.
Figure 1 Anti-CD22 Monoclonal Antibody (V3S-0522-YC6553) in ELISA
Figure 2 Anti-CD22 Monoclonal Antibody (V3S-0522-YC6553) in WB
Western blot analysis of V3S-0522-YC6553 was performed by loading Human CD22 Protein (His Tag) in reduced condition Lane 1 (0.8 μg) onto a 12% Tris-HCl polyacrylamide gel. Proteins were transferred to a CN membrane and blocked with 5% skim milk for at least one hour. Membranes were probed with V3S-0522-YC6553 (2 μg/mL) and HRP-conjugated goat anti-mouse IgG as a secondary antibody (1: 6000). Chemiluminescent detection was performed.
Figure 2 Anti-CD22 Monoclonal Antibody (V3S-0522-YC6553) in WB
Figure 3 Anti-CD22 Monoclonal Antibody (V3S-0522-YC6553) in DB
Dot Blot analysis of V3S-0522-YC6553 was performed by coating with Human CD22 Protein (His Tag).
V3S-0522-YC6553 incubation concentration: 2 μg/mL.
HRP-conjugated goat anti-mouse IgG as a secondary antibody (1: 6000)
Figure 3 Anti-CD22 Monoclonal Antibody (V3S-0522-YC6553) in DB
Figure 4 Anti-CD22 Monoclonal Antibody (V3S-0522-YC6553) in FACS
Flow cytometry analysis of Daudi cells (0.5x106) with purified antibody V3S-0522-YC6553 (5 μl). Cells were blocked with Human TruStain FcXTM and washed with 0.5% BSA-PBS. An Alexa Fluor 488 goat anti-mouse IgG(H+L) (5 μl) as a secondary antibody.
Figure 4 Anti-CD22 Monoclonal Antibody (V3S-0522-YC6553) in FACS
